• Facebook
  • Twitter
  • Youtube
  • Instagram
  • LinkedIn
  • Rss
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2021 State of Cancer Survivorship Survey
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • Nominations
      • Awardees
      • Committees
      • Sponsors
    • Cancer Policy Roundtable (CPR)
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2021 State of Survivorship Survey Results Briefing
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Your generous year-end donation will be matched $1 for $1    DONATE

Dome Thumbnail starburst

NCCS Offers Policy Comments: Strategies for Increasing Patient Participation in FDA Review Activities

December 9, 2014/in Cancer News, Cancer Policy Blog, FDA, NCCS News, Policy Comments Access to Care, Clinical Trials NCCS News, Policy Comments /by actualize

The Food and Drug Administration Safety and Innovation Act (FDASIA) authorized a patient-focused drug development program, and in the years since enactment, the U.S. Food and Drug Administration (FDA) has implemented certain initiatives of the patient-focused program. In recent weeks, FDA has requested feedback regarding patient-focused activities to date and recommendations about future efforts and NCCS was pleased to submit comments.

NCCS commends the FDA for including patient representatives on advisory committees and including periods of public comment but notes that the participation of the public is encouraged too late in the drug development and review process. In our comments, we advise the FDA to engage with patients earlier in the development process so it can better leverage the insights and experience of patients and patient advocates.

In addition, we commend the agency for being diligent in managing conflicts of interest to promote transparency regarding the relationships that patients and patient advocates have with product sponsors, but we are concerned that the current standards for determining conflicts of interest might block patient participation in FDA activities. We recommend a public discussion regarding the current application of the rules take place to better examine the issue.

Tags: Cancer Survivorship, clinical trials, FDA, policy comments, quality
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
https://canceradvocacy.org/wp-content/uploads/2012/12/Dome_Thumbnail_starburst.png 125 125 actualize http://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2014-12-09 09:41:522020-10-21 09:15:29NCCS Offers Policy Comments: Strategies for Increasing Patient Participation in FDA Review Activities

Latest News

Kara Kenan Advocate Spotlight

Kara Kenan: Helping Others is the Greatest Reward of Advocacy

August 3, 2022
“Nobody wins afraid of losing” rings true for Kara Kenan, a breast cancer survivor. It’s her favorite line from Chris Stapleton’s…
Read more
https://canceradvocacy.org/wp-content/uploads/Advocate-Spotlight-Kara-Kenan.jpg 600 1200 NCCS Staff http://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2022-08-03 12:20:482022-08-03 12:20:48Kara Kenan: Helping Others is the Greatest Reward of Advocacy
Care and Career Support From Health Systems to Employers Webinar

Webinar – Care and Career Support: From Health Systems to Employers

August 3, 2022
NCCS hosted a webinar about the unique demands of caregiving in cancer and strategies that employers and health systems might engage…
Read more
https://canceradvocacy.org/wp-content/uploads/Care-and-Career-Support-webinar-post-1200px.jpg 600 1200 NCCS Staff http://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2022-08-03 10:24:462022-08-03 10:24:46Webinar – Care and Career Support: From Health Systems to Employers
Bethany Ross

Bethany Ross: Advocating for Quality Cancer Care Through Storytelling

July 7, 2022
Advocate Spotlight July 2022 - Bethany Ross Bethany Ross is a four-year neuroendocrine cancer survivor, or “cancer badass,”…
Read more
https://canceradvocacy.org/wp-content/uploads/Advocate-Spotlight-Bethany-Ross-web.jpg 600 1200 NCCS Staff http://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2022-07-07 16:53:522022-07-07 16:53:52Bethany Ross: Advocating for Quality Cancer Care Through Storytelling

Take Action

Make An Impact

We are relentless in improving the quality of care and life after a cancer diagnosis. Your support makes all the difference right now.

Make a Gift »

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • This field is for validation purposes and should be left unchanged.
  • About
    • Our Mission
    • Our History
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2021 State of Cancer Survivorship Survey
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • Nominations
      • Awardees
      • Committees
      • Sponsors
    • Cancer Policy Roundtable (CPR)
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2021 State of Survivorship Survey Results Briefing
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

WCOE: Comparing Health Plans, Motivating Change in Clinical Practice, the Sunshine... NCCS Starburst Thumbnail Dome Thumbnail starburst NCCS Policy Comments: Recommending Cancer Survivorship as a Topic for FDA Patient-Focused...
Scroll to top
Get Updates From NCCS

Be the first to hear about cancer policy and survivorship issues! Subscribe and receive the biweekly NCCS Health Care Roundup, invites to webinars and events, and more.

  • This field is for validation purposes and should be left unchanged.

Connect With Us

Twitter     Facebook     Instagram     LinkedIn     YouTube

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute